Ria Wolkorte1, Dorothea J Heersema2, Inge Zijdewind1. 1. Department of Neuroscience, University Medical Center Groningen, University of Groningen, The Netherlands. 2. Department of Neurology, University Medical Center Groningen, The Netherlands.
Abstract
BACKGROUND: Multiple sclerosis (MS) can be accompanied by motor, cognitive, and sensory impairments. Additionally, MS patients often report fatigue as one of their most debilitating symptoms. It is, therefore, expected that MS patients will have difficulties in performing cognitive-motor dual tasks (DTs), especially in a fatiguing condition. OBJECTIVE: To determine whether MS patients are more challenged by a DT than controls in a fatiguing and less-fatiguing condition and whether DT performance is associated with perceived fatigue. METHODS: A group of 19 MS patients and 19 age-, sex-, and education-matched controls performed a cognitive task (2-choice reaction time task) separately or concurrent with a low-force or a high-force motor task (index finger abduction at 10% or 30% maximal voluntary contraction). RESULTS: MS patients performed less well on a cognitive task than controls. Cognitive task performance under DT conditions decreased more for MS patients. Moreover, under high-force DT conditions, cognitive performance declined in both groups but to a larger degree for MS patients. Besides a decline in cognitive task performance, MS patients also showed a stronger decrease in motor performance under high-force DT conditions. DT costs were positively related to perceived fatigue as measured by questionnaires. CONCLUSIONS: Compared with controls, MS patients performed less well on DTs as demonstrated by a reduction in both cognitive and motor performances. This performance decrease was stronger under fatiguing conditions and was related to the sense of fatigue of MS patients. These data illustrate problems that MS patients may encounter in daily life because of their fatigue.
BACKGROUND:Multiple sclerosis (MS) can be accompanied by motor, cognitive, and sensory impairments. Additionally, MSpatients often report fatigue as one of their most debilitating symptoms. It is, therefore, expected that MSpatients will have difficulties in performing cognitive-motor dual tasks (DTs), especially in a fatiguing condition. OBJECTIVE: To determine whether MSpatients are more challenged by a DT than controls in a fatiguing and less-fatiguing condition and whether DT performance is associated with perceived fatigue. METHODS: A group of 19 MSpatients and 19 age-, sex-, and education-matched controls performed a cognitive task (2-choice reaction time task) separately or concurrent with a low-force or a high-force motor task (index finger abduction at 10% or 30% maximal voluntary contraction). RESULTS:MSpatients performed less well on a cognitive task than controls. Cognitive task performance under DT conditions decreased more for MSpatients. Moreover, under high-force DT conditions, cognitive performance declined in both groups but to a larger degree for MSpatients. Besides a decline in cognitive task performance, MSpatients also showed a stronger decrease in motor performance under high-force DT conditions. DT costs were positively related to perceived fatigue as measured by questionnaires. CONCLUSIONS: Compared with controls, MSpatients performed less well on DTs as demonstrated by a reduction in both cognitive and motor performances. This performance decrease was stronger under fatiguing conditions and was related to the sense of fatigue of MSpatients. These data illustrate problems that MSpatients may encounter in daily life because of their fatigue.
Authors: Scott K Powers; Gordon S Lynch; Kate T Murphy; Michael B Reid; Inge Zijdewind Journal: Med Sci Sports Exerc Date: 2016-11 Impact factor: 5.411
Authors: Jeffrey R Gould; Andrew E Reineberg; Brice T Cleland; Kristi E Knoblauch; Grace K Clinton; Marie T Banich; John R Corboy; Roger M Enoka Journal: Front Physiol Date: 2018-10-17 Impact factor: 4.566
Authors: Paula M Ellison; Stuart Goodall; Niamh Kennedy; Helen Dawes; Allan Clark; Valerie Pomeroy; Martin Duddy; Mark R Baker; John M Saxton Journal: Neuropsychol Rev Date: 2021-05-07 Impact factor: 6.940